Methotrexat-Therapie bei schwerer chronischer okulärer Graft versus
                    Host Disease (GvHD)

Klin Monbl Augenheilkd 2013; 230(4): 344-345
DOI: 10.1055/s-0032-1328334

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Methotrexate Treatment in Severe Chronic Ocular Graft versus Host Disease (GvHD)

Authors

S. Sabti

¹Augenklinik, Universitätsspital Basel, Universität Basel, Schweiz, Chefarzt Prof. Josef Flammer
J. P. Halter

²Hämatologie, Universitätsspital Basel, Universität Basel, Schweiz, Chefarzt Prof. Jakob Passweg
M. M. Bosch

³Augenklinik, Universitätsspital Zürich, Universität Zürich, Schweiz, Chefärztin Prof. Klara Landau
D. Goldblum

¹Augenklinik, Universitätsspital Basel, Universität Basel, Schweiz, Chefarzt Prof. Josef Flammer

Literatur
1 Wolff D, Bertz H, Greinix H et al. The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland. Dtsch Arztebl Int 2011; 108: 732-740
2 Dietrich-Ntoukas T, Cursiefen C, Westekemper H et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 2012; 31: 299-310
3 Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735
4 Ruutu T, Niederwieser D, Gratwohl A et al. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT. Bone Marrow Transplant 1997; 19: 759-764
5 Messmer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea 1995; 14: 408-417
6 Huang XJ, Jiang Q, Chen H et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 343-348